Edgestream Partners, L.P. Royalty Pharma PLC Transaction History
Edgestream Partners, L.P.
- $2.88 Billion
- Q1 2025
A detailed history of Edgestream Partners, L.P. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Edgestream Partners, L.P. holds 21,158 shares of RPRX stock, worth $694,617. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,158Holding current value
$694,617% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
483Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.35 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$756 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$440 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$399 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...